CPAP Machine Research:CAGR of 8.6% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "CPAP Machines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.



CPAP, or Continuous Positive Airway Pressure, delivers pressurized ambient air (regular room air) through a delivery system (tubing and mask), thus eliminating apnea events during sleep. CPAP is the most effective treatment for sleep apnea and can potentially improve the patient's sleep overnight; dramatically improving the quality of life for individuals afflicted with obstructive sleep apnea. CPAP devices are frequently used in prehospital and emergency settings.



【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/2341569/cpap-machines





CPAP Machine Market Summary

According to the new market research report "Global CPAP Machine Market Report 2023-2029", published by QYResearch, the global CPAP Machine market size is projected to reach USD 4.54 billion by 2029, at a CAGR of 8.6% during the forecast period.

Global CPAP Machine MarketSize(US$ Million), 2018-2029
240806-165704.webp (13 KB)

Based on or includes research from QYResearch: Global CPAP Machine Market Report 2023-2029.

Global CPAP Machine Top18Players Ranking and Market Share（Continually updated）
240806-165724.webp (22 KB)

Based on or includes research from QYResearch: Global CPAP Machine Market Report 2023-2029.

According to QYResearch Top Players Research Center, the global key manufacturers of CPAP Machine include ResMed, Fisher & Paykel Healthcare, BMC Medical, Philips, Weinmann Emergency Medical, Breas Medical, SLS Medical Technology, Nidek Medical India, Wellell, Hunan Beyond Medical, etc. In 2022, the global top five players had a share approximately 72.0% in terms of revenue.

CPAP Machine,Global Market Size, Split by Product Segment
240806-165750.webp (18 KB)



Based on or includes research from QYResearch: Global CPAP Machine Market Report 2023-2029.

In terms of product type, currently CPAP is the largest segment, hold a share of 49.2%.

CPAP typically is used for people who have breathing problems, such as sleep apnea. CPAP also may be used to treat preterm infants whose lungs have not yet fully developed. For example, physicians may use CPAP in infants with respiratory distress syndrome. It is associated with a decrease in the incidence of bronchopulmonary dysplasia. In some preterm infants whose lungs have not fully developed, CPAP improves survival and decreases the need for steroid treatment for their lungs. In resource-limited settings where CPAP improves respiratory rate and survival in children with primary pulmonary disease, researchers have found that nurses can initiate and manage care with once or twice daily physician rounds.

CPAP therapy utilizes machines specifically designed to deliver a constant flow of pressure. Some CPAP machines have other features as well, such as heated humidifiers. CPAP is the most effective treatment for obstructive sleep apnea, in which the mild pressure from the CPAP prevents the airway from collapsing or becoming blocked.

The global sleep apnea devices market is expected to witness substantial growth owing to high prevalence of Obstructive Sleep Apnea (OSA) patients. Downsides of urban lifestyle such as long working hours, obesity, diabetes, and anxiety have resulted in increased sleep disorders, consequently driving sleep apnea devices demand. Leading market players have invested heavily in the development of compact therapeutic devices, which is expected to favorably impact sleep apnea devices market growth.

Restraint:

Unlike CPAP, combined surgery and DISE pose a promising and potentially curative approach to treating adult OSA, therefore warranting greater attention and consequently further research efforts focusing on surgical outcomes.

Oral appliances (eg, mandibular advancement devices, tongue retaining devices) are an alternative therapeutic strategy in OSA that may be offered to patients with mild to moderate OSA who decline or fail to adhere to positive airway pressure therapy and who have a preference for such treatment.

Oral appliances - For patients with mild or moderate OSA who decline or fail to adhere to positive airway pressure therapy, an oral appliance is a reasonable alternative to positive airway pressure. This is based upon the recognition that while positive airway pressure is generally more effective than an oral appliance at normalizing respiratory events and oxyhemoglobin desaturation episodes during sleep, most patients prefer an oral appliance, adherence is an essential aspect of successful treatment, both modalities are effective compared to no treatment or a sham treatment, and both modalities have a similar effect on symptoms and quality of life.

Upper airway surgery - There is no consensus regarding the role of surgery in patients with OSA of varying degrees of severity, nor have optimal screening or imaging procedures been established that accurately predict which patients are most likely to benefit from surgery. We generally consider surgical therapy when positive airway pressure or an oral appliance is declined or ineffective (after at least a three month trial of therapy). Surgical treatment appears to be most effective in patients who have OSA due to a severe, surgically correctable, obstructing lesion of the upper airway. Examples of surgically correctable lesions that may obstruct the upper airway include tonsillar hypertrophy, adenoid hypertrophy, or craniofacial abnormalities.

Hypoglossal nerve stimulation via an implantable neurostimulator device is a treatment strategy that may have a role in selected patients with moderate to severe OSA, who have failed continuous positive airway pressure with a body mass index

About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 17 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.